The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder
NCT03195465 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2021-06-02
Summary
The purpose of this study is to determine if routine consumption of high antioxidant cacao can have an effect on the behaviors of children with Autism Spectrum Disorder. This is proposed as children with Autism Spectrum Disorder have elevated oxidative stress markers, such as, free radicals making them highly vulnerable to oxidative damage. Thus, it is proposed that foods high in antioxidant activity can offer protection against oxidative stress and thus impact behaviors.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Dark Chocolate
Dark Chocolate bars with 70% cacao and 30% organic cane sugar where 4 squares of the dark chocolate will be administered twice daily between the hours of 6 a.m. and 6 p.m. daily for four weeks.
Sponsors & Collaborators
-
Loma Linda University
lead OTHER
Principal Investigators
-
Lee Berk, DrPH · Loma Linda University
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-14
- Primary Completion
- 2018-04-01
- Completion
- 2018-04-01
Countries
- United States
Study Locations
More Related Trials
-
Effect of Increasing Total Antioxidant Capacity in Autism Spectrum Disorder
NCT06623227 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Dates as a Functional Food for Autism
NCT04261595 ·Status: COMPLETED ·Phase: NA
-
Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism
NCT00263367 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Study of N-Acetyl Cysteine in Children With Autism
NCT00676195 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hyperbaric Oxygenation Therapy on Adaptive, Aberrant and Stereotyped Behaviors in Children With Autism
NCT00404846 ·Status: UNKNOWN ·Phase: NA
-
A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder
NCT03008889 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
NCT03835117 ·Status: COMPLETED ·Phase: PHASE2
-
Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder
NCT02909959 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
NCT00453180 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder
NCT02879110 ·Status: COMPLETED ·Phase: NA
-
Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children
NCT00631215 ·Status: UNKNOWN ·Phase: NA
-
Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD)
NCT02561481 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study
NCT00324909 ·Status: COMPLETED ·Phase: NA
-
A Controlled Trial of the Clinical Effects of Hyperbaric Therapy in Autistic Children
NCT00335790 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism
NCT00584480 ·Status: COMPLETED ·Phase: PHASE3
-
Coaching Children With Anxiety and Autism Through Telehealth
NCT05588570 ·Status: COMPLETED ·Phase: NA
-
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
NCT03757585 ·Status: COMPLETED ·Phase: PHASE4
-
Transcranial Photobiomodulation for Reducing Autism Symptoms in Children
NCT04660552 ·Status: COMPLETED ·Phase: NA
-
Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response
NCT02414451 ·Status: WITHDRAWN ·Phase: NA
-
Optimizing Outcomes for Young Autistic Children
NCT05926687 ·Status: RECRUITING ·Phase: PHASE2
-
Combined Effects of Early Behavioral Intervention and Propranolol on ASD
NCT02428205 ·Status: COMPLETED ·Phase: NA
-
Oxidative Stress and Vitamin D Levels in Autism Spectrum Disorders
NCT06983379 ·Status: COMPLETED
-
Galantamine Versus Placebo in Childhood Autism
NCT00252603 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders
NCT00859664 ·Status: UNKNOWN
-
Improving Social Interaction for Adolescents With Autism During the Transition to Adulthood
NCT03785327 ·Status: TERMINATED ·Phase: NA